Novo Nordisk
Company announcement
Novo Nordisk – major shareholder announcement
Bagsværd
, De
n
mark,
1
4 February
202
2 – Novo Nordisk today announced that the company has
been notified by BlackRock, Inc. (Blackrock) that Blackrock as of 8
February 2022 holds B shares equal to 5.05% of the entire share
capital of Novo Nordisk. The announcement is in accordance with
section 30 of the Danish Capital Markets Act.
The total B shares according to section 38 of the Danish Capital Markets Act, and other financial instruments according to section 39(2)(1) of the Danish Capital Markets Act and financial instruments with similar effects according to section 39(2)(2) of the Danish Capital Markets Act held by Blackrock correspond to 5.07% of the entire share capital and below 5% of the voting rights.
For a full chain of controlled undertakings through which the voting rights and/or the financial instruments are held, please see the annex.
A
bout Novo Nordisk
Novo Nordisk is a leading global healthcare company, founded in
1923 and headquartered in Denmark. Our purpose is to drive change to
defeat diabetes and other serious chronic diseases such as obesity
and rare blood and endocrine disorders. We do so by pioneering
scientific breakthroughs, expanding access to our medicines and
working to prevent and ultimately cure disease. Novo Nordisk employs
about 4
7
,
8
00 people in 80 countries and markets its products in around 170
countries. Novo Nordisk's B shares are listed on Nasdaq Copenhagen
(Novo-B). Its ADRs are listed on the New York Stock Exchan
ge (NVO)
.
Further information
| Media: | ||
| Martin Havtorn Petersen | +45 3075 5246 | mhpz@novonordisk.com |
| Michael Bachner (US) | +1 609 664 7308 | mzyb@novonordisk.com |
| Investors: | ||
| Daniel Muusmann Bohsen | +45 3075 2175 | dabo@novonordisk.com |
| Ann Søndermølle Rendbæk | +45 3075 2253 | arnd@novonordisk.com |
| David Heiberg Landsted | +45 3077 6915 | dhel@novonordisk.com |
| Jacob Martin Wiborg Rode | +45 3075 5956 | jrde@novonordisk.com |
| Mark Joseph Root (US) | +1 848 213 3219 | mjhr@novonordisk.com |
Company announcement No 12 / 2022
Annex
| Name | % of voting rights if it equals or is higher than the notifiable threshold | % of voting rights through financial instruments if it equals or is higher than the notifiable threshold | Total of both if it equals or is higher than the notifiable threshold |
| BlackRock Japan Co., Ltd. | Below 5% | ||
| BlackRock Investment Management, LLC | Below 5% | ||
| BlackRock Investment Management (UK) Limited | Below 5% | ||
| BlackRock Investment Management (Australia) Limited | Below 5% | ||
| Blackrock International Limited | Below 5% | ||
| BlackRock Fund Advisors | Below 5% | ||
| BlackRock Financial Management, Inc. | Below 5% | ||
| BlackRock Asset Management North Asia Limited | Below 5% | ||
| BlackRock Asset Management Deutschland AG | Below 5% | ||
| BlackRock Asset Management Canada Limited | Below 5% | ||
| BlackRock Advisors, LLC | Below 5% | ||
| BlackRock (Singapore) Limited | Below 5% | ||
| BlackRock Asset Management Ireland Limited | Below 5% | ||
| Aperio Group, LLC | Below 5% |
Attachment
